[go: up one dir, main page]

FI871419L - Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning. - Google Patents

Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning. Download PDF

Info

Publication number
FI871419L
FI871419L FI871419A FI871419A FI871419L FI 871419 L FI871419 L FI 871419L FI 871419 A FI871419 A FI 871419A FI 871419 A FI871419 A FI 871419A FI 871419 L FI871419 L FI 871419L
Authority
FI
Finland
Prior art keywords
quinoline
carboxylic acid
acid derivatives
deras framstaellning
framstaellning och
Prior art date
Application number
FI871419A
Other languages
English (en)
Other versions
FI871419A7 (fi
FI871419A0 (fi
Inventor
Masayuki Iwata
Tomio Kimura
Yoshimi Fujiwara
Tetsushi Katsube
Original Assignee
Sankyo Co
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP61313852A external-priority patent/JPS62228063A/ja
Application filed by Sankyo Co, Ube Industries filed Critical Sankyo Co
Publication of FI871419A0 publication Critical patent/FI871419A0/fi
Publication of FI871419A7 publication Critical patent/FI871419A7/fi
Publication of FI871419L publication Critical patent/FI871419L/fi
Priority to FI953246A priority Critical patent/FI101962B1/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI871419A 1986-03-31 1987-03-31 Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning. FI871419L (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI953246A FI101962B1 (fi) 1986-03-31 1995-06-30 Välituotteet kinoliini-3-karboksyylihappojohdannaisten valmistamiseksi

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7406486 1986-03-31
JP22512086 1986-09-24
JP61313852A JPS62228063A (ja) 1985-12-27 1986-12-24 キノリンカルボン酸誘導体

Publications (3)

Publication Number Publication Date
FI871419A0 FI871419A0 (fi) 1987-03-31
FI871419A7 FI871419A7 (fi) 1987-10-01
FI871419L true FI871419L (fi) 1987-10-01

Family

ID=27301402

Family Applications (1)

Application Number Title Priority Date Filing Date
FI871419A FI871419L (fi) 1986-03-31 1987-03-31 Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning.

Country Status (6)

Country Link
EP (1) EP0241206A3 (fi)
CN (1) CN1019114B (fi)
AU (1) AU618235B2 (fi)
DK (1) DK164287A (fi)
FI (1) FI871419L (fi)
NO (1) NO871333L (fi)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039683A (en) * 1987-10-26 1991-08-13 Pfizer Inc. Azetidinyl quinolone carboxylic acids and esters
FR2625200A1 (en) * 1987-12-29 1989-06-30 Esteve Labor Dr 7-(1-Azetidinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid derivatives, their preparation and their application as medicaments
FR2634483B2 (fr) * 1987-12-29 1994-03-04 Esteve Labor Dr Derives des acides 7-(1-azetidinyl)-1,4-dihydro-4-oxoquinoleine-3-carboxyliques, leur preparation et leur application en tant que medicaments
DE3814517A1 (de) * 1988-02-05 1989-08-17 Bayer Ag Chinolon- und naphthyridoncarbonsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US5173484A (en) * 1988-02-05 1992-12-22 Bayer Aktiengesellschaft Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
JPH0395177A (ja) * 1988-05-19 1991-04-19 Chugai Pharmaceut Co Ltd 新規キノロンカルボン酸誘導体
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
FI95130C (fi) * 1988-07-20 1995-12-27 Sankyo Co Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi
FR2654728B2 (fr) * 1989-03-16 1994-09-23 Esteve Labor Dr Derives d'acides pyridone carboxyliques azetidinyl substitues, leur preparation et leur application en tant que medicament.
FR2644455B1 (fr) * 1989-03-16 1994-09-23 Esteve Labor Dr Derives d'acides pyridone carboxyliques azetidinyl substitues, leur preparation et leur application en tant que medicaments
NO177302C (no) * 1989-03-16 1995-08-23 Esteve Labor Dr Analogifremgangsmåte til fremstilling av terapeutisk aktive substituerte azetidinylkinolon(naftyridon)karboksylsyrederivater
FI921475A0 (fi) * 1989-10-06 1992-04-03 Pfizer 1,4-dihydro-4-oxo-3-kinolinderivat som selektivt toxiska antibakteriella aemenn hos daeggdjur.
US5385913A (en) * 1989-10-06 1995-01-31 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
JPH0778065B2 (ja) * 1990-07-06 1995-08-23 杏林製薬株式会社 (6,7―置換―8―アルコキシ―1―シクロプロピル―1,4―ジヒドロ―4―オキソ―3―キノリンカルボン酸―o▲上3▼,o▲上4▼)ビス(アシルオキシ―o)ホウ素化合物及びその塩並びにその製造方法
FR2674247B1 (fr) * 1991-03-19 1993-07-16 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
GR910100517A (el) * 1991-12-30 1993-08-31 Kyorin Seiyaku Kk Δις(ακυλοξυ-ο) βορικος εστερας του (6,7-υποκατεστημενου-8-αλκοξυ-1- κυκλοπροπυλ-1,4,-διυδρο-4-οξο-3-κινολινοκαρβοξυλικου οξεως-ο3,ο4)και αλας αυτου, και μεθοδος παρασκευης αυτου.
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
FR2706459B1 (fr) * 1993-06-17 1995-08-04 Bouchara Sa Nouveaux dérivés quinoloniques, leur procédé d'obtention et les compositions pharmaceutiques qui en contiennent.
AU8003594A (en) * 1993-10-28 1995-05-22 Kaken Pharmaceutical Co., Ltd. Quinolinecarboxylic acid derivative and salt thereof
JP3449658B2 (ja) * 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた8−アルコキシキノロンカルボン酸水和物並びにその製造方法
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
EP1253149B1 (en) * 2000-02-01 2007-09-12 Kyorin Pharmaceutical Co., Ltd. Sulfate salt of quinolonecarboxylic acid derivative and use thereof
US6608078B2 (en) 2000-05-08 2003-08-19 Wockhardt Limited Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment
US7098219B2 (en) 2000-08-01 2006-08-29 Wockhart Limited Inhibitors of cellular efflux pumps of microbes
US6878713B2 (en) 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
WO2003099815A1 (en) 2002-05-28 2003-12-04 Wockhardt Limited Crystalline fluoroquinolone arginine salt form
BR0318460A (pt) 2003-09-04 2006-09-12 Wockhardt Ltd sal de arginina de ácido benzoquinolizina-2-carboxìlico tetrahidratado
WO2005026145A2 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
WO2005026165A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
SI1675852T1 (sl) * 2003-09-22 2009-06-30 Janssen Pharmaceutica Nv 7-amino alkilidenil-heterociklični kinoloni in naftiridoni
ES2232309B1 (es) * 2003-11-13 2006-08-01 Quimica Sintetica, S.A. Procedimiento simplificado para la obtencion de gatifloxacino.
SI21799A (sl) * 2004-06-30 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo gatifloksacina in regeneracija razpadnih produktov
DE102004035203A1 (de) 2004-07-21 2006-02-16 Bayer Healthcare Ag Substituierte Chinolone
US7732612B2 (en) * 2004-09-09 2010-06-08 Janssen Pharmaceutica, N.V. 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
CN1301254C (zh) * 2004-09-28 2007-02-21 南京圣和药业有限公司 加替沙星的制备及纯化方法
CN100341855C (zh) * 2005-02-22 2007-10-10 南京澳新医药科技有限公司 7-取代-8-甲氧基氟喹诺酮羧酸衍生物、制法、制剂及其用途
DE102005030524A1 (de) 2005-06-30 2007-01-18 Aicuris Gmbh & Co. Kg Substituierte Chinolone II
AR054608A1 (es) 2005-08-08 2007-06-27 Actelion Pharmaceuticals Ltd Derivados de oxazolidinona enlazados a quinolonas como antibacterianos
DE102006005861A1 (de) 2006-02-09 2007-08-23 Aicuris Gmbh & Co. Kg Substituierte Chinolone III
CL2007003332A1 (es) 2006-11-24 2008-06-20 Actelion Pharmaceuticals Ltd Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
JP6030146B2 (ja) 2011-11-08 2016-11-24 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd 2−オキソ−オキサゾリジン−3,5−ジイル抗生物質誘導体
US10087171B2 (en) 2016-12-19 2018-10-02 Actelion Pharmaceuticals Ltd Crystalline forms of cadazolid
CN114989165B (zh) * 2022-05-30 2024-11-08 青岛大学附属医院 一种抗持留菌和生物膜菌的化合物或组合物及其用途
CN116606279A (zh) * 2023-03-13 2023-08-18 广东工业大学 一种氟喹诺酮类化合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0090424B1 (en) * 1982-03-31 1986-05-28 Sterling Drug Inc. New quinolone compounds and preparation thereof
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
JPS59128383A (ja) * 1982-12-29 1984-07-24 Kanebo Ltd 新規キノリンカルボン酸誘導体および該化合物を有効成分とする抗菌剤
DE3577089D1 (de) * 1984-01-26 1990-05-17 Abbott Lab Antibakterielle chinolinderivate.
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた8‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
JPS62205060A (ja) * 1986-03-04 1987-09-09 Kyorin Pharmaceut Co Ltd 8位置換キノロンカルボン酸誘導体

Also Published As

Publication number Publication date
AU618235B2 (en) 1991-12-19
FI871419A7 (fi) 1987-10-01
CN1019114B (zh) 1992-11-18
NO871333D0 (no) 1987-03-31
FI871419A0 (fi) 1987-03-31
DK164287D0 (da) 1987-03-31
EP0241206A3 (en) 1989-05-10
NO871333L (no) 1987-10-01
AU7078587A (en) 1987-10-08
DK164287A (da) 1987-10-01
EP0241206A2 (en) 1987-10-14
CN87103693A (zh) 1988-03-30

Similar Documents

Publication Publication Date Title
FI871419L (fi) Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning.
FI875484A7 (fi) Fosfinsyraderivat.
FI862029L (fi) Askorbinsyraderivat, deras framstaellning och anvaendning.
FI860832A0 (fi) Tiazolidinderivat, deras framstaellning och anvaendning.
FI865369A7 (fi) N-innehaollande fusionerade heterocykliska foereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI870349A7 (fi) Foerfarande och anordning foer behandling av vaetskor, i synnerhet foer anrikning av vatten med syre.
FI871828A0 (fi) Substituerade benzamidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI870394A7 (fi) Kinonderivat, deras framstaellning och anvaendning.
FI875202A0 (fi) Steroider med en spiranring i 17-staellning, foerfarande foer framstaellning av dessa och anvaendning av dessa.
FI871719L (fi) Tiolaktam-n-aettiksyraderivat, deras framstaellning och anvaendning.
FI872091A7 (fi) Kinolinkarboxylsyraderivat och deras framstaellning.
FI870769A7 (fi) Alkoxylerade, katjoniskt modifierade amidpolymerer och foerfarande foer deras framstaellning.
FI892675L (fi) 2,6-dihalogenpyridin-3 -karboxylsyraderivat och deras framstaellning.
FI874020A7 (fi) Tetrahydrokinolinderivat, foerfarande foer deras framstaellning, deras anvaendning och dessa innehaollande farmaceutiska preparat.
FI872230L (fi) Katalysatorharts, vilket anvaends foer katalytisk reduktion av syre i vattenhaltiga medier, och foerfarande foer framstaellning av detta.
FI874548L (fi) Hydroxikarboxylsyraderivat, foerfarande foer deras framstaellning och deras anvaendning i tryck- eller vaermekaensliga maerkmaterial.
FI863358A0 (fi) Aminosyra-derivat, foerfarande foer deras framstaellning och anvaendning.
FI875759A0 (fi) Foerfarande och anordning foer maskinell plantering, i synnerhet plantering av unga traed.
FI863489A0 (fi) Foerfarande och anordning foer aotervinning av i gaser befintliga foeroreningar, isynnerhet loesningsmedel.
FI863480L (fi) Azolyl-cyklopropyl-etanolderivat, foerfarande foer deras framstaellning och deras anvaendning.
FI870342A7 (fi) Aminderivator, foerfarande foer deras framstaellning och deras anvaendning.
FI870293A7 (fi) 8 -acylaminoergoliner, deras framstaellning och dessa innehaollande farmaceutiska kompositioner.
FI864854A0 (fi) Foerfarande och anordning foer foerpackning av en rulle, i synnerhet en pappersrulle.
FI864706L (fi) Foerfarande och anordning foer hantering av pappersrullar i en anlaeggning, saosom tryckeri.
FI864705A0 (fi) Foerfarande och anordning foer hantering av pappersrullar i en anlaeggning, saosom tryckeri.

Legal Events

Date Code Title Description
FC Application refused
FC Application refused

Owner name: SANKYO COMPANY LIMITED

Owner name: UBE INDUSTRIES, LIMITED